Rights and permissions
About this article
Cite this article
Endometrial screening during tamoxifen therapy unlikely to be cost-beneficial. React. Wkly. 685, 2 (1998). https://doi.org/10.2165/00128415-199806850-00001
Published:
Issue Date:
DOI: https://doi.org/10.2165/00128415-199806850-00001